CIK 0001609809 · Non-accelerated filer<br>Smaller reporting company
Seres Therapeutics, Inc.
Sign in to watch- Ticker
- MCRB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 274326290
- Phone
- 617 945 9626
- Business address
- 200 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- Seres Therapeutics, Inc., Seres Health, Inc.
- CT ORDER Other Confidential Order
- S-8 Other Securities Offered to Employees in Benefit Plans
- DEFA14A Proxy Proxy Materials
- S-8 Other Securities Offered to Employees in Benefit Plans
- DEFA14A Proxy Proxy Materials
- EFFECT Other Notice of Effectiveness
- CT ORDER Other Confidential Order
- DEFA14A Proxy Proxy Materials
- S-8 Other Securities Offered to Employees in Benefit Plans
- S-8 Other Securities Offered to Employees in Benefit Plans
- EFFECT Other Notice of Effectiveness
- S-1MEF Other S-1MEF
- CERTNAS Other Certification by the Nasdaq Stock Market
- 8-A12B Other Registration of Securities
- DRS/A Other Draft Registration Statement
- DRS/A Other Draft Registration Statement
- DRS/A Other Draft Registration Statement
- D Other Notice of Sales of Unregistered Securities
- DRS Other Draft Registration Statement
- D Other Notice of Sales of Unregistered Securities
Page 3 of 4 · 61 filings